We are live on ! Find out more
RHBC

R.H. Bluestein & Co Portfolio holdings

AUM $1.61B
1-Year Est. Return 7.59%
This Fund
S&P 500
This Quarter Est. Return
-16.25%
1 Year Est. Return
-7.59%
3 Year Est. Return
+69.02%
5 Year Est. Return
+139.59%
10 Year Est. Return
–
AUM
$1.63B
AUM Growth
-$758M
Cap. Flow
-$358M
Cap. Flow %
-22.01%
Top 10 Hldgs %
47.54%
Holding
408
New
22
Increased
69
Reduced
110
Closed
53

Top Buys

Rank Stock Value
1
ADI icon
Analog Devices
ADI
+$21.2M
2
LLY icon
Eli Lilly
LLY
+$19.2M
3
MCD icon
McDonald's
MCD
+$9.1M
4
DHI icon
D.R. Horton
DHI
+$8.44M
5
LIN icon
Linde
LIN
+$8.43M

Top Sells

Rank Stock Value
1
HD icon
Home Depot
HD
+$53.8M
2
UPS icon
United Parcel Service
UPS
+$49.1M
3
PANW icon
Palo Alto Networks
PANW
+$48.1M
4
GS icon
Goldman Sachs
GS
+$45.4M
5
CVX icon
Chevron
CVX
+$41.4M

Sector Composition

Rank Sector Weight
1 Technology 23.86%
2 Industrials 17.87%
3 Healthcare 12.42%
4 Consumer Discretionary 9.18%
5 Consumer Staples 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BP icon
126
BP
BP
$114B
$731K 0.04%
25,791
-10,025
-28% -$307K
DHR icon
127
Danaher
DHR
$139B
$730K 0.04%
3,249
+564
+21% +$130K
SYY icon
128
Sysco
SYY
$40.7B
$726K 0.04%
8,575
-300
-3% -$25.1K
OTIS icon
129
Otis Worldwide
OTIS
$27.5B
$715K 0.04%
10,115
– –
APD icon
130
Air Products & Chemicals
APD
$65.2B
$699K 0.04%
2,908
– –
AZN icon
131
AstraZeneca
AZN
$245B
$699K 0.04%
5,288
+125
+2% +$16.4K
CP icon
132
Canadian Pacific Kansas City
CP
$79.7B
$698K 0.04%
10,000
– –
UL icon
133
Unilever
UL
$137B
$687K 0.04%
13,333
– –
NVS icon
134
Novartis
NVS
$292B
$685K 0.04%
8,100
-2,000
-20% -$175K
SPEM icon
135
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.3B
$679K 0.04%
19,532
+5,525
+39% +$200K
AMAT icon
136
Applied Materials
AMAT
$411B
$673K 0.04%
7,400
-102,020
-93% -$11.2M
ABB
137
DELISTED
ABB Ltd
ABB
$668K 0.04%
25,000
– –
APTV icon
138
Aptiv
APTV
$12.1B
$665K 0.04%
7,470
-88,825
-92% -$9.06M
ISRG icon
139
Intuitive Surgical
ISRG
$133B
$654K 0.04%
3,260
+1
+0% +$235
BHP icon
140
BHP
BHP
$212B
$646K 0.04%
11,500
-3,634
-24% -$226K
NEE icon
141
NextEra Energy
NEE
$181B
$644K 0.04%
8,311
-5,004
-38% -$381K
ENB icon
142
Enbridge
ENB
$118B
$641K 0.04%
15,175
– –
TM icon
143
Toyota
TM
$220B
$617K 0.04%
4,000
– –
VYM icon
144
Vanguard High Dividend Yield ETF
VYM
$81.4B
$609K 0.04%
5,986
– –
BNS icon
145
Scotiabank
BNS
$108B
$592K 0.04%
10,000
– –
VALE icon
146
Vale
VALE
$62B
$585K 0.04%
40,000
-5,000
-11% -$85.4K
CNH
147
CNH Industrial
CNH
$13.4B
$580K 0.04%
50,000
-10,000
-17% -$142K
ALV icon
148
Autoliv
ALV
$9.07B
$573K 0.04%
8,000
– –
SM icon
149
SM Energy
SM
$7.66B
$568K 0.03%
16,600
-2,500
-13% -$102K
HIT
150
DELISTED
HITACHI LTD ADR (10COM)NEW
HIT
$567K 0.03%
6,000
– –
4 5
6
7 8

Similar funds

BDF
Balasa Dinverno & Foltz $1.58B AUM 17.55% 1-Year Est. Return
ACM
AlphaCrest Capital Management New York $1.64B AUM 23.4% 1-Year Est. Return
SCA
Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return
WFA
Wipfli Financial Advisors Milwaukee, Wisconsin $1.42B AUM 20.63% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
CA
Capitolis Advisors New York $1.41B AUM 17.33% 1-Year Est. Return
RIG
Roosevelt Investment Group New York $1.39B AUM 5.42% 1-Year Est. Return
CCP
Corient Capital Partners Newport Beach, California $1.34B AUM 12.46% 1-Year Est. Return

R.H. Bluestein & Co's Q2 2022 Portfolio in Review

As of Q2 2022, R.H. Bluestein & Co held 408 positions worth $1.63B, down 32% from $2.39B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

R.H. Bluestein & Co withdrew a net $358M in Q2 2022, closing 53 positions and reducing 110 holdings. Its most notable exit was Goldman Sachs, an estimated $45.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, R.H. Bluestein & Co opened a new position in Eli Lilly worth $20.7M.

  • R.H. Bluestein & Co's largest Q2 2022 buy was Eli Lilly: 63,984 shares worth $20.7M.
  • R.H. Bluestein & Co added most to Analog Devices in Q2 2022, an estimated $21.2M increase.
  • R.H. Bluestein & Co's biggest Q2 2022 reduction was Home Depot, cutting an estimated $53.8M.
  • R.H. Bluestein & Co fully exited Goldman Sachs in Q2 2022, selling an estimated $45.4M.
  • R.H. Bluestein & Co's ten largest holdings make up 48% of its $1.63B portfolio in Q2 2022.
  • R.H. Bluestein & Co opened 22 new positions and closed 53 in Q2 2022.
  • R.H. Bluestein & Co's portfolio value fell 32% quarter-over-quarter to $1.63B.

Based on R.H. Bluestein & Co's 13F filing for Q2 2022, filed 11 Aug 2022.